Mindera Health, Inc., a San Diego, CA-based firm growing and commercializing next-generation medical know-how to allow a brand new period of pores and skin analytics on the molecular degree, closed a $14M convertible notice financing.
The spherical was led by Mountain Group Companions and different present traders in anticipation of a Collection B financing in 2025.
Proceeds will help the continued commercialization of Mindera’s lead product, Thoughts.Px™.
Led by Ron Rocca, CEO, Mindera Well being is an organization growing and commercializing next-generation medical know-how to allow a brand new period of pores and skin analytics on the molecular degree. Utilizing a proprietary dermal biomarker patch, next-generation sequencing, and machine studying, Mindera Well being know-how generates clinically validated information to scale back healthcare system prices and enhance affected person outcomes.
Thoughts.Px™ is the flagship take a look at of Mindera Well being, designed to prospectively predict a affected person’s response to biologic drug lessons previous to therapeutic choice and remedy. It makes use of a scalable, minimally invasive dermal biomarker patch that captures over 7,000 biomarkers per pattern together with information analytics,
Mindera Well being is a CLIA- and CAP-certified laboratory and has obtained ISO 13485:2016 certification.
FinSMEs
01/08/2024
